Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial

Published:2024-02-26 Issue: Volume: Page:
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Zhu Xiaoyun¹,Li Weinan²³⁴,Yang Yi²,Li Hengfei²³⁴,Yang Min⁵,Zhang Jilong⁶,Li Xucheng⁷,Yan Guangjun⁸,Wu Xiongfei⁹,Zhao Weijun¹⁰,Cui Mengdi¹,Yang Xi¹,Hu Xinyu¹,Huang Juan¹,Ba Yuanming²³⁴

Affiliation:

1. Hubei University of Chinese Medicine, Wuhan, China

2. Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China

3. The Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China

4. Hubei Provincial Academy of Traditional Chinese Medicine, Wuhan, China

5. Hubei University of Chinese Medicine, Department of Preventive Medicine, School of Basic Medicine, Wuhan, China

6. Wuhan NO.1 Hospital, Fever Clinic, Wuhan, China

7. Wuhan Hospital of Traditional Chinese Medicine, Emergency Department, Wuhan, China

8. Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, China

9. People’s Hospital of Hanchuan, Department of Infectious Diseases, Hanchuan, China

10. Yichang Hospital of Traditional Chinese Medicine, Respiratory Department, Yichang, China

Publisher

Impact Journals, LLC

Reference14 articles.

1. Inhibiting virus replication and excessive inflammatory response: Mechanism of combined prescription of Ma-Xing-Shi-Gan decoction and Xiao-Chai-Hu decoction against influenza virus.;Ban;J Ethnopharmacol,2023

2. Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial.;Yang;Front Pharmacol,2023

3. The Important Role of Volatile Components From a Traditional Chinese Medicine Dayuan-Yin Against the COVID-19 Pandemic.;Huang;Front Pharmacol,2020

4. A Multi-center Clinical Study on 451 Cases of Coronavirus Disease Treated with “Pneumonia No. 1 Formula”.;Zuo;World Chinese Medicine,2020

5. Study of “Pneumonia No. 1 Formula” in the Treatment of COVID-19.;Wu;Lishizhen Medicine and Materia Medica Research,2020